DERMATOLOGIST EXECUTIVE TEAM WITH FRONT-LINE CLINICAL EXPERIENCE
Reid Waldman, MD
Chief Executive Officer and Board Member
Dr. Waldman is the Chief Executive Officer of Veradermics. Under his stewardship, he has positioned Veradermics for rapid growth by implementing a differentiated strategy centered on advancing first-in-class therapeutics for under-innovated markets in dermatology. He has also successfully led the company through two equity financings raising proceeds of more than $23M and has advanced Veradermics lead asset, VDMN, an immunostimulatory dissolvable microarray for the treatment of warts into a 150-subject, Phase 2 clinical trial.
Dr. Waldman is a board-certified dermatologist with more than 10 years of clinical experience. Prior to founding Veradermics, Dr. Waldman was a prolific researcher authoring more than 100 publications including a textbook titled “Dermatology for the Primary Care Provider.” He has been the recipient of numerous accolades including the American Academy of Dermatology’s “Excellence in Patient Care” award. He earned his Bachelor of Liberal Arts and his Medical Degree from the University of Missouri-Kansas City 6 Year BA/MD Program and completed his dermatology residency with a “Distinction in Clinical Trials” at the University of Connecticut.
Tim Durso, MD
President and Board Member
Dr. Durso is the President of Veradermics heading research and development for the company. Dr. Durso is a board-certified Dermatologist by training with more than 10 years of clinical experience.
Dr. Durso is a recognized expert in innovation for both drug and device domains within the field of dermatology having authored a number of peer-reviewed articles and book chapters on a variety of subjects. He has also been awarded national recognition for his work including being named a Resident of Distinction by the DermMentors Foundation and a past Grand Prize Winner of MIT Hacking Dermatology. His educational background includes a Bachelor of Science degree magna cum laude from the University of Notre Dame and his Medical Degree summa cum laude from Loyola University Chicago.
Jane Grant-Kels, MD
Chief Medical Officer and Board Member
Dr. Grant-Kels is an internationally renowned dermatologist and dermatology researcher. She has served as the founding Chair of the Department of Dermatology at the University of Connecticut.
She has also been on the board of directors of the Women’s Dermatology Society, the American Academy of Dermatology, and the Association of Dermatology Program Directors. Her research prowess has resulted in her serving as the founding Editor-in-Chief of the Journal of Clinical Medicine the founding Co-Editor-in-Chief of the International Journal of Women’s Dermatology, Deputy Editor of the Journal of the American Academy of Dermatology, and the Associate Editor for Dermatology for the Annals of Medicine. She has published over 475 peer reviewed manuscripts, 157 chapters, guest edited 24 journals, and edited or co-authored 8 books. She has delivered hundreds of invited lectures throughout the US.